High detection rates of pancreatic cancer across stages by plasma assay of novel methylated DNA markers and CA 19-9

BACKGROUND & AIMS: We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case-control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC. METHODS: Thirteen MDMs (GRIN2D, CD1D, ZNF781, FER1L4,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Majumder, Shounak, Taylor, William R., Foote, Patrick H., Berger, Calise K., Wu, Chung Wah, Mahoney, Douglas W., Bamlet, William R., Burger, Kelli N., Postier, Neil, de la Fuente, Jaime, Doering, Karen A., Lidgard, Graham P., Allawi, Hatim T., Petersen, Gloria M., Chari, Suresh T., Ahlquist, David A., Kisiel, John B.
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102343/
https://ncbi.nlm.nih.gov/pubmed/33593879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-0235
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars